109 results
Page 2 of 6
6-K
EX-99.1
hp618 k8t65xqx
10 Aug 22
Report of Foreign Private Issuer
9:05am
6-K
EX-99.1
zf4fwd3k
8 Jun 22
BiondVax receives supportive Scientific Advice from the Paul Ehrlich
6:27am
6-K
EX-99.1
kd4f61w 37lu6w0z
3 Jun 22
BiondVax Announces First Quarter 2022 Financial Results and Provides Business Update
4:05pm
6-K
EX-99.1
1urgzr g90vhgq83z
13 May 22
Report of Foreign Private Issuer
7:48am
6-K
EX-99.2
cccp562d2jmfn5fly93
13 May 22
Report of Foreign Private Issuer
7:48am
6-K
EX-99.1
3ks8dfn7dmqshu6d
4 Apr 22
Report of Foreign Private Issuer
5:19pm
6-K
EX-99.1
tsbubpuznmt8n1j7hk
11 Jan 22
Report of Foreign Private Issuer
6:06am
6-K
EX-99.1
xqeywh70 9eg4wjsvh2p
30 Dec 21
Former CFO of GSK’s Global Vaccines Business Mr. Jay Green Joins BiondVax’s Board of Directors
4:15pm
424B5
jjyih5zc lxl4hjty
28 Dec 21
Prospectus supplement for primary offering
5:20pm
424B5
icikmsewz6ohum 2e
27 Dec 21
Prospectus supplement for primary offering
6:22am
6-K
EX-99.1
djwqvuz02g
22 Dec 21
Report of Foreign Private Issuer
4:15pm
6-K
EX-99.1
9yxw2u2q05wx
13 Dec 21
Report of Foreign Private Issuer
7:34am
6-K
EX-99.1
bduukus
2 Dec 21
BiondVax announces Third Quarter 2021 Financial Results and Provides Business Update
4:15pm
6-K
EX-99.1
jnm5gwlmi3h30
24 Nov 21
BiondVax Announces Notice of Annual General Meeting of Shareholders and Provides a Business Update
3:06pm
6-K
EX-99.1
443x9nj 51ldegjlw9
25 Oct 21
BiondVax advances its growth strategy towards a new pipeline based on innovative VHH antibodies
6:04am
6-K
EX-99.1
uqz0wbq h47
26 Aug 21
BiondVax Announces Second Quarter 2021 Financial Results and Provides Business Update
4:32pm
6-K
EX-99.1
yarganf9s 3zx4w
23 Jun 21
BiondVax Announces First Quarter 2021 Financial Results and Provides Business Update
9:40am
6-K
EX-99.1
0xr9rk
13 May 21
BiondVax Announces Fourth Quarter and Full Year 2020 Financial Results
5:17pm